Overview
Ruiyu Mou practices practicing medicine in Tianjin, China.
Their clinical expertise encompasses Cerebral Hypoxia, Squamous Cell Lung Carcinoma, Prostate Cancer, and Familial Prostate Cancer.
They are actively involved in clinical research, co-authoring 10 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ruiyu Mou
Is Ruiyu Mou a top-rated expert for Cerebral Hypoxia?
MediFind is an objective health platform that identifies experts based on real-world data. Ruiyu Mou is classified as an Experienced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ruiyu Mou participate in research or clinical trials?
Yes. Ruiyu Mou has published 10 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of Ruiyu Mou's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cerebral HypoxiaMou isExperienced. Learn about Cerebral Hypoxia.
- Familial Prostate CancerMou isExperienced. Learn about Familial Prostate Cancer.
- Lung CancerMou isExperienced. Learn about Lung Cancer.
- Prostate CancerMou isExperienced. Learn about Prostate Cancer.
- Squamous Cell Lung Carcinoma